Profile data is unavailable for this security.
About the company
Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.
- Revenue in PLN (TTM)1.31m
- Net income in PLN-3.83m
- Incorporated2011
- Employees16.00
- LocationBraster SASzeligi, ul. Cichy Ogrod 7 05-850PolandPOL
- Phone+48 222950350
- Fax+48 222950351
- Websitehttps://www.braster.eu/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Rented Sector SA | 200.00k | 27.20k | 9.25m | -- | 339.97 | -- | 98.65 | 46.25 | 0.0206 | 0.0206 | 0.1514 | -0.035 | 1.79 | -- | 2.20 | -- | 24.28 | 1,266.23 | -- | -- | 23.89 | -1,935.55 | 13.60 | 2,755.44 | -- | -- | -- | -- | -- | -- | -66.26 | -- | -- | -- |
| Inno-Gene SA | 1.13m | -1.46m | 9.81m | 27.00 | -- | 1.49 | -- | 8.69 | -0.2559 | -0.2559 | 0.1979 | 1.16 | 0.1086 | 4.67 | 0.673 | -- | -14.04 | 7.92 | -19.07 | 10.73 | 39.18 | 73.63 | -129.34 | 11.59 | 2.58 | -- | 0.0362 | -- | -93.08 | -16.73 | -542.12 | -- | -- | -- |
| Braster SA | 1.31m | -3.83m | 16.24m | 16.00 | -- | -- | -- | 12.42 | -0.2825 | -0.2825 | 0.0561 | -0.1734 | 0.0601 | 0.0769 | 163.38 | -- | -17.61 | -29.23 | -220.50 | -50.27 | 71.16 | 68.77 | -293.04 | -1,435.54 | 0.3061 | -2.59 | 1.62 | -- | 413.76 | 41.35 | 42.87 | -- | -- | -- |
| Sygnis SA | 15.75m | -8.22m | 18.17m | -- | -- | -- | -- | 1.15 | -0.3614 | -0.3614 | 0.6925 | -- | -- | -- | -- | -- | -- | -6.10 | -- | -9.57 | 50.82 | 56.46 | -53.74 | -22.44 | -- | -10.62 | -- | -- | -33.38 | 44.26 | -266.18 | -- | -- | -- |
| Cannabis Poland SA | 199.93k | -675.76k | 20.00m | -- | -- | 51.94 | -- | 100.04 | -0.0255 | -0.0255 | 0.0076 | 0.0111 | 0.3018 | 0.8264 | 5.07 | -- | -102.76 | -116.92 | -175.94 | -136.30 | 26.16 | 12.29 | -340.53 | -959.39 | 1.35 | -45.88 | 0.2547 | -- | -47.55 | 50.23 | 14.30 | -- | -- | -- |
| Nanogroup SA | -23.32k | -1.82m | 20.70m | -- | -- | 2.82 | -- | -- | -0.06 | -0.06 | -0.0013 | 0.3655 | -0.0013 | 44.40 | -- | -- | -9.95 | -17.12 | -12.41 | -19.06 | -- | -276.06 | -- | -1,180.74 | 1.09 | -- | 0.0088 | -- | -71.66 | 27.88 | 91.62 | -- | -38.43 | -- |
| Stem Cells Spin SA | 419.32k | -154.01k | 21.70m | -- | -- | 2.92 | 23.30 | 51.75 | -0.0037 | -0.0037 | 0.0101 | 0.1797 | 0.0294 | 0.0746 | 1.57 | -- | -1.08 | -1.14 | -1.76 | -1.93 | 89.36 | 94.37 | -36.73 | -45.34 | 0.0363 | -124.05 | 0.0153 | -- | 68.84 | -4.37 | -678.77 | -- | -52.67 | -- |
| Genxone SA | 2.39m | -3.72m | 22.68m | -- | -- | 1.52 | -- | 9.47 | -1.13 | -1.13 | 0.7265 | 4.54 | 0.1358 | 13.39 | 5.04 | -- | -21.09 | 14.58 | -22.04 | 16.46 | -23.18 | 48.42 | -155.31 | 20.41 | 16.91 | -- | 0.0039 | -- | -77.38 | 111.39 | -874.87 | -- | -28.78 | -- |
| Pure Biologics SA | 109.00k | -31.72m | 25.94m | 53.00 | -- | 1.99 | -- | 237.95 | -11.15 | -11.15 | 0.0377 | 4.05 | 0.0023 | -- | 0.1026 | 1,135.42 | -66.46 | -48.68 | -81.74 | -83.38 | -3,960.55 | 38.81 | -29,097.25 | -195.73 | -- | -11.41 | 0.7606 | -- | 160.63 | -7.58 | -117.62 | -- | -- | -- |
| GENOMED SA | 22.48m | 996.34k | 39.11m | -- | 39.25 | 3.86 | 24.22 | 1.74 | 0.7541 | 0.7541 | 17.01 | 7.66 | 2.00 | 6.29 | 13.81 | -- | 8.87 | 7.90 | 10.24 | 9.33 | 42.85 | 38.56 | 4.43 | 3.93 | 4.10 | 3,257.61 | -- | -- | 9.85 | 3.87 | 193.38 | -7.69 | -32.19 | -- |
| Inventionmed SA | 610.00 | -2.46m | 43.70m | 9.00 | -- | 8.15 | -- | 71,640.38 | -0.0121 | -0.0121 | 0.00 | 0.0264 | 0.00002 | -- | 0.0004 | 67.78 | -7.00 | -18.09 | -11.73 | -23.28 | -1,288.53 | -48.77 | -403,196.70 | -43,186.79 | -- | -2.11 | -- | -- | -85.01 | -- | 88.90 | -- | -- | -- |
| BIOGENED SA | 95.56m | 4.20m | 60.43m | 205.00 | 14.37 | -- | 7.82 | 0.6323 | 1.71 | 1.71 | 38.90 | -- | -- | -- | -- | 466,145.20 | -- | 2.92 | -- | 4.13 | 66.42 | 68.04 | 4.40 | 3.31 | -- | 3.68 | -- | -- | 20.02 | 18.88 | 24.33 | 29.89 | 9.88 | -- |
| Medicofarma Biotech SA | 750.81k | -2.67m | 63.22m | -- | -- | 6.36 | -- | 84.20 | -0.0393 | -0.0393 | 0.011 | 0.1463 | 0.0468 | 3.57 | 1.51 | -- | -16.65 | -13.16 | -21.54 | -15.86 | 65.45 | 29.92 | -355.88 | -37.81 | 0.6358 | -14.54 | -- | -- | -82.34 | -31.48 | -68.11 | -- | -- | -- |
Data as of May 04 2023. Currency figures normalised to Braster SA's reporting currency: Polish New Zloty PLN
